Human myeloma IgA half-molecules

Area of Science:

• Immunology
• Molecular Biology
• Protein Chemistry

Background:

• Multiple myeloma is a cancer of plasma cells.
• Immunoglobulin A (IgA) myeloma is a subtype characterized by abnormal IgA production.
• Understanding IgA structure is crucial for diagnosing and treating myeloma.

Observation:

• A patient with multiple myeloma produced a lambda IgA1 paraprotein.
• Analytical ultracentrifugation revealed 7.0S and 4.5S protein peaks, suggesting half-molecules.
• Electrophoresis indicated the presence of covalently linked heavy and light chains.

Findings:

• The myeloma protein consisted of two-chain half-molecules with a truncated alpha heavy chain (46,500 Da vs. 55,000 Da).
• Antigenic analysis showed deficiency in the Fc portion of the alpha chain.
• Reduced noncovalent interactions between alpha chains were observed, likely due to Fc deletion.

Implications:

• The findings suggest a potential genetic mutation leading to IgA1 half-molecule production.
• This structural abnormality may represent a novel IgA1 variant.
• Further research could elucidate the role of Fc deletions in immunoglobulinopathies.